Skip to main content
Premium Trial:

Request an Annual Quote

Enzo Biochem Buys Biomol International for $18M

NEW YORK (GenomeWeb News) – Enzo Biochem said today that it has acquired the US assets and stock of the two UK subsidiaries of Biomol International for $18 million in cash and stock, plus earn-outs over the next two years.
Privately held Biomol sells enzymes, peptides, substrates, and antibodies for signal transduction, lipid research, apoptosis, neuroscience and drug discovery, with a research focus on the functional proteomics field. The firm has annual revenues of roughly $11.5 million with 9 percent annual growth, according to New York-based Enzo.
“Coupling Biomol with our acquisition of Axxora Life Sciences less than a year ago, we have succeeded in transforming Enzo Life Sciences into a global manufacturer and marketer of reagents and systems spanning a wide spectrum of scientific applications,” Barry Weiner, president of Enzo, said in a statement.
Biomol has 50 employees in the US and UK. Enzo did not say whether they would all join the firm’s operations. However, it said that Biomol’s senior management and founders would remain “actively involved” with Enzo.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.